InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nuvation Bio Inc.

NUVB Clue Score46
United States Fiscal year ends December CIK 0001811063
$5.00 +1.01% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.00 −46.81% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 24 Aug 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−43.6Net income−41.7Fiscal year 2021Operating income−93.3Net income−86.8EPS, diluted−0.44Fiscal year 2022Operating income−119.7Net income−104.2EPS, diluted−0.48Fiscal year 2023Revenue0.0Operating income−99.8Net income−75.8EPS, diluted−0.35Fiscal year 2024Revenue7.9Operating income−592.6Net income−567.9EPS, diluted−2.11Fiscal year 2025Revenue62.9 +699.0%Operating income−213.1Net income−204.6EPS, diluted−0.60
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 0.0 7.9 62.9
Growth +699.0%
Operating income −43.6 −93.3 −119.7 −99.8 −592.6 −213.1
Net income −41.7 −86.8 −104.2 −75.8 −567.9 −204.6
Growth
EPS, diluted n/a −0.44 −0.48 −0.35 −2.11 −0.60
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Gross margin10.1%Operating margin−7,527.3%Net margin−7,213.8%Fiscal year 2025Operating margin−338.7%Net margin−325.3%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a 10.1% n/a
Operating margin n/a n/a n/a n/a −7,527.3% −338.7%
Net margin n/a n/a n/a n/a −7,213.8% −325.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2020Operating cash flow−36.5Fiscal year 2021Operating cash flow−68.2Fiscal year 2022Operating cash flow−96.1Fiscal year 2023Operating cash flow−68.0Fiscal year 2024Operating cash flow−130.4Fiscal year 2025Operating cash flow−173.4
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −36.5 −68.2 −96.1 −68.0 −130.4 −173.4

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash29.8Shareholders’ equity215.1Fiscal year 2021Cash132.4Shareholders’ equity746.0Fiscal year 2022Cash101.1Shareholders’ equity655.1Fiscal year 2023Cash42.6Shareholders’ equity605.1Fiscal year 2024Cash35.7Shareholders’ equity463.8Fiscal year 2025Cash164.1Total debt47.2Net cash (debt)116.9Shareholders’ equity305.7Debt to equity0.15
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 29.8 132.4 101.1 42.6 35.7 164.1
Total debt n/a n/a n/a n/a n/a 47.2
Net cash (debt) n/a n/a n/a n/a n/a 116.9
Shareholders’ equity 215.1 746.0 655.1 605.1 463.8 305.7
Debt to equity n/a n/a n/a n/a n/a 0.15

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a n/a 10.1% n/a
n/a n/a n/a n/a −7,527.3% −338.7%
n/a n/a n/a n/a −7,213.8% −325.3%
n/a n/a n/a n/a −7,213.8% −325.3%
Spending
n/a n/a n/a n/a 1,259.0% 183.0%
n/a n/a n/a n/a 879.4% 240.9%
Returns
−19.4% −11.6% −15.9% −12.5% −122.5% −66.9%
−18.8% −11.2% −15.5% −12.2% −105.1% −34.4%
Balance and payout
n/a n/a n/a n/a n/a 0.15
3.0% 3.9% 2.5% 2.6% 14.2% 48.6%